References & Contributions

Because many advisory activities are conducted under confidentiality agreements, this page highlights selected public roles, contributions and representative areas of work rather than client-specific assignments.

 

Selected Public Roles and Professional Contexts

 

• Founder, InVitroTox Consulting

• Director, Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine SAS

• European Registered Toxicologist (ERT)

• ESTIV president

• OECD expert in areas of topical toxicity and validation  

• Former CEO of MatTek In Vitro Life Science Laboratories (now part of Sartorius) 

• Experience across academia, industry and collaborative scientific activities

• Public expert contribution in advanced in vitro toxicology and non-animal methods

 

Selected Areas of Contribution

​

Advanced in vitro toxicology

Human-relevant in vitro approaches, reconstructed tissue models and applied toxicology. Protocols development, modifications necessary to match desired sensitivity and specificity, and protocol transfers amongst the different tissue models. 

​

Validation-oriented development

Method evaluation, refinement and scientific positioning for robust and credible use.

Management of validation studies and teams.

 

Scientific review and protocol quality

Review of workflows, protocols and documentation with emphasis on clarity, consistency and interpretability.

 

Training and knowledge transfer

Lectures, workshops and expert sessions supporting a stronger understanding and implementation of in vitro methods, strategies and GLP/GIVIMP principles.

 

Examples of Advisory Support

​

• Method readiness review

• Validation-oriented scientific strategy

• Regulatory readiness 

• Protocol and SOP review

• Auditing 

• Scientific advisory for teams and EU projects

• Training and expert sessions

 

Selected Publications, Talks and Public Outputs 

For a full scientific profile, please visit Helena Kandarova’s personal website.

​

​